Download App

Weight Loss Medications: Types, Side Effects, Benefits and How They Work

Summary

Modern weight loss medications, particularly GLP-1 receptor agonists like semaglutide and dual GIP/GLP-1 agents like tirzepatide, work by suppressing appetite, slowing digestion, and regulating blood sugar through the body’s hormonal pathways. Clinical trials show average weight reductions of up to 14.9% with semaglutide and 22.5% with tirzepatide, making them the most effective non-surgical options available. All are Schedule H prescription medicines in India, best used alongside diet and lifestyle changes, with weight regain likely if stopped without a long-term management plan.

Key Takeaways

GLP-1 receptor agonists and dual GIP/GLP-1 agents are the most clinically validated weight loss medicines available today
Work by reducing appetite, slowing digestion, and improving blood sugar through the body’s own hormonal pathways
Semaglutide produces up to 14.9% average weight reduction; tirzepatide up to 22.5% over 72 weeks
Suited for BMI 27.5+ or 22.5+ with a weight-related condition such as type 2 diabetes, PCOS, or MASLD
Once-weekly injectable or daily oral options available depending on patient preference
Schedule H prescription medicines — require a registered doctor’s prescription in India
Most effective as part of a supervised programme including diet, activity, and regular monitoring
Weight regain is likely if treatment stops without sustained lifestyle changes

For many people, weight does not respond to diet and exercise the way it is supposed to. Hunger stays high, energy stays low, and the body seems to actively resist change. This is not a failure of willpower. In many cases, it reflects a genuine disruption in the hormonal and metabolic systems that govern how the body stores fat, regulates appetite, and uses energy.

Weight loss medications work by addressing these underlying mechanisms directly. Over the past decade, a new generation of medicines has transformed what is medically possible for patients with obesity and related conditions, producing levels of weight loss that were simply not achievable with older drugs.

This guide covers the main types of weight loss medications available today, how they work, who they are suited for, and what to be aware of before starting treatment.

Who Are Weight Loss Medications For?

Weight loss medications are prescription treatments designed for patients with a clinical need, not for people looking to lose a small amount of weight for cosmetic reasons.

Based on BMI thresholds, weight loss medications are generally considered appropriate for:

Adults with a BMI of 27.5 or above
Adults with a BMI of 22.5 or above who have at least one weight-related condition such as type 2 diabetes, high blood pressure, high cholesterol, PCOS, PCOD, sleep apnoea, or metabolic dysfunction-associated steatotic liver disease (MASLD)
Patients who have made sustained efforts with diet and lifestyle changes for at least six months without achieving adequate results

Conditions that make weight loss medication particularly relevant include obesity, type 2 diabetes, PCOS and PCOD, sleep apnoea, and MASLD. In each of these, excess body weight is not just a symptom; it actively worsens the underlying condition, and treating the weight is part of treating the disease.

Types of Weight Loss Medications

Several classes of weight loss medication are used in clinical practice today, each working through a distinct mechanism. Here are the main options and how they differ.

1. GLP-1 Receptor Agonists

GLP-1 receptor agonists are currently the most clinically supported class of weight loss medications available. They mimic glucagon-like peptide-1, a gut hormone naturally released after eating, and activate receptors across the brain, pancreas, and digestive system to reduce hunger, slow digestion, and improve blood sugar regulation.

Semaglutide is the most widely used GLP-1 agent for weight management. It is available as a once-weekly injection (under brand names including Ozempic, Wegovy, Alterme, Obesema, Olymviq, Hepaglide, and Livarise) and as a daily oral tablet (Rybelsus). Injectable semaglutide at higher doses has produced average weight reductions of up to 14.9% over 68 weeks in large clinical trials^[¹^].

Liraglutide is an earlier GLP-1 agent administered as a daily injection. It produces more modest weight loss than semaglutide but has a well-established safety record and remains a used option in some clinical settings^[²^].

2. Dual GIP and GLP-1 Receptor Agonists

This is the newest and most potent class of weight loss medication currently approved. Rather than targeting one hormonal pathway, these medicines activate two simultaneously, GLP-1 receptors and GIP (glucose-dependent insulinotropic polypeptide) receptors, producing additive effects on appetite, fat metabolism, and blood sugar control.

Tirzepatide (Mounjaro) is the only approved medicine in this class. The SURMOUNT-1 clinical trial^[³^] reported average body weight reductions of 16% at the 5mg dose and up to 22.5% at the 15mg dose over 72 weeks, outcomes historically associated only with bariatric surgery. For patients with obesity and significant comorbidities, tirzepatide currently represents the most effective non-surgical option available.

3. Oral Weight Loss Medications

For patients who are averse to injections, oral options exist within the GLP-1 class.

Oral semaglutide (Rybelsus) contains the same active molecule as injectable semaglutide but is formulated as a tablet. The PIONEER trial^[⁴^] programme found that the 14mg dose produced weight reductions of around 4.4kg over 26 weeks in patients with type 2 diabetes. The effect is more modest than injectable forms, but it is clinically meaningful and offers a useful starting point for patients who wish to begin GLP-1 therapy without injections.

Oral semaglutide must be taken on an empty stomach with no more than 120ml of plain water, at least 30 minutes before the first meal or drink of the day. Taking it with food significantly reduces absorption.

How Do Weight Loss Medications Work?

Different medications work through different mechanisms, but the most effective modern options share a common foundation in hormonal signalling:

Appetite regulation: GLP-1 and dual GIP/GLP-1 medications act on receptors in the hypothalamus, the brain’s hunger control centre, reducing appetite, lowering interest in food between meals, and increasing satisfaction from smaller portions.
Slowed gastric emptying: These medicines slow the rate at which food leaves the stomach, extending the feeling of fullness after meals and naturally reducing overall calorie intake.
Insulin and glucagon regulation: By stimulating insulin release when blood sugar rises and suppressing glucagon between meals, these medications improve blood sugar control in a glucose-dependent way, meaning they act when needed, keeping the risk of hypoglycaemia low.
Dual hormonal action: Tirzepatide adds GIP receptor activation to the above, influencing how fat tissue responds to insulin and how the body manages energy storage. This dual action is why its weight loss outcomes exceed those of GLP-1 agents alone.

Benefits of Weight Loss Medications

For patients who meet the clinical criteria, weight loss medications offer a range of well-documented benefits beyond the number on the scale:

Sustained weight reduction over months of consistent treatment, unlike the short-term losses typical of restrictive diets
Improved blood sugar control and reduced HbA1c in patients with type 2 diabetes or insulin resistance
Meaningful reductions in blood pressure and cholesterol over time
Reduction in liver fat in patients with MASLD or fatty liver disease
Decreased severity of obstructive sleep apnoea with weight reduction
Hormonal improvements in women with PCOS and PCOD, including better insulin sensitivity and, in some cases, more regular menstrual cycles
Reduced cardiovascular risk, with trial data showing lower rates of major cardiac events in high-risk patients

These benefits are most consistent when medications are used alongside dietary changes and regular physical activity, and under ongoing medical supervision.

Side Effects of Weight Loss Medications

Weight loss medications such as GLP-1 receptor agonists and dual agonists are generally well tolerated when prescribed appropriately and introduced gradually. However, like all medicines, they can cause side effects, particularly during the early stages of treatment.

Common side effects: Most are gastrointestinal and occur in the first few weeks as the body adjusts:

Nausea: Most frequently reported; settles with titration and smaller meals
Vomiting: Less common; eating slowly and avoiding large meals helps
Diarrhoea: Usually temporary and self-resolving
Constipation: Managed with adequate hydration and fibre intake
Bloating and abdominal discomfort: Mild and typically short-lived

Starting at a low dose and eating smaller, lower-fat meals during the adjustment period reduces these considerably.

Less common but notable side effects include:

Mild increases in heart rate with some GLP-1 agents
Headache and fatigue, particularly in the initial weeks
Injection site reactions with injectable formulations

Who should not use these medications:

Patients with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia Type 2 (MEN-2)
Patients with a history of pancreatitis
Women who are pregnant, planning to become pregnant, or breastfeeding
Patients with severe gastrointestinal conditions affecting motility, such as gastroparesis

Drug interactions: GLP-1 and dual agonist medications slow gastric emptying, which can affect the absorption of other oral medicines. Always inform your doctor of every medication, supplement, and vitamin you are currently taking before starting treatment.

Important Considerations Before Starting

Weight loss medications are not a short-term fix. Most clinical guidelines now treat obesity as a chronic condition requiring long-term medical management, and the weight loss achieved with these medicines is generally maintained only while treatment continues. Stopping without a plan typically leads to weight regain.

Regular monitoring is important throughout treatment. Your doctor will usually track body weight, blood sugar levels, blood pressure, liver health, and any side effects at scheduled intervals.

These medicines work best as part of a broader programme, one that includes genuine dietary changes, physical activity, and ongoing medical oversight. Used in that context, the results can be genuinely transformative for patients who have struggled with weight despite their best efforts.

Conclusion

Weight loss medications have moved well beyond the stimulant-based appetite suppressants of earlier decades. The GLP-1 receptor agonists and dual GIP/GLP-1 agents available today are backed by substantial clinical trial evidence and represent a meaningful advance in how obesity and its related conditions are treated.

For patients with a clinical need, whether that is obesity, type 2 diabetes, PCOS, sleep apnoea, or MASLD, these medications can deliver results that diet and exercise alone cannot reliably achieve. If your weight has not responded adequately to lifestyle changes, a conversation with your doctor about medically supervised treatment is a reasonable and well-supported next step.

FAQs About Weight Loss Medications

1. What are the most effective weight loss medications available in India?
Semaglutide-based injectables (Ozempic, Wegovy, Obesema, Olymviq, Alterme, Hepaglide, Livarise) and tirzepatide (Mounjaro) currently have the strongest clinical evidence. Tirzepatide produces the greatest average weight loss of any approved medication. The right choice depends on your BMI, comorbidities, injection preference, and your doctor’s recommendation.

2. Are weight loss medications safe for long-term use?
GLP-1 receptor agonists have been studied in trials lasting up to five years, with a favourable safety profile compared to older weight loss drugs. Long-term use should always be guided and monitored by a doctor.

3. Do weight loss medications require a prescription in India?
Yes. GLP-1 and dual agonist weight loss medications are Schedule H prescription medicines in India. They can only be dispensed with a valid prescription from a registered medical practitioner.

4. How quickly do weight loss medications produce results?
Most patients notice a reduction in appetite within two to four weeks. Measurable weight loss typically becomes evident after four to eight weeks, with peak results seen over six to twelve months of continued treatment.

5. What happens when weight loss medication is stopped?
Weight regain after discontinuing GLP-1 or dual agonist therapy is well documented. This reflects the chronic nature of obesity as a metabolic condition. Any decision to stop medication should be made in consultation with your doctor, not independently.